American National Insurance’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-11,925
| Closed | -$1.43M | – | 270 |
|
|
2021
Q3 | $1.43M | Hold |
11,925
| – | – | 0.05% | 239 |
|
|
2021
Q2 | $1.43M | Hold |
11,925
| – | – | 0.05% | 234 |
|
|
2021
Q1 | $1.19M | Hold |
11,925
| – | – | 0.05% | 245 |
|
|
2020
Q4 | $1.19M | Hold |
11,925
| – | – | 0.05% | 229 |
|
|
2020
Q3 | $1.31M | Hold |
11,925
| – | – | 0.06% | 202 |
|
|
2020
Q2 | $1.26M | Hold |
11,925
| – | – | 0.07% | 205 |
|
|
2020
Q1 | $1.06M | Hold |
11,925
| – | – | 0.07% | 196 |
|
|
2019
Q4 | $1.19M | Sell |
11,925
-1,250
| -9% | -$118K | 0.06% | 207 |
|
|
2019
Q3 | $1.17M | Hold |
13,175
| – | – | 0.06% | 208 |
|
|
2019
Q2 | $1.09M | Hold |
13,175
| – | – | 0.06% | 212 |
|
|
2019
Q1 | $1.06M | Hold |
13,175
| – | – | 0.06% | 213 |
|
|
2018
Q4 | $1M | Hold |
13,175
| – | – | 0.06% | 209 |
|
|
2018
Q3 | $1.04M | Hold |
13,175
| – | – | 0.05% | 218 |
|
|
2018
Q2 | $925K | Hold |
13,175
| – | – | 0.05% | 257 |
|
|
2018
Q1 | $921K | Hold |
13,175
| – | – | 0.05% | 255 |
|
|
2017
Q4 | $914K | Hold |
13,175
| – | – | 0.05% | 257 |
|
|
2017
Q3 | $893K | Hold |
13,175
| – | – | 0.05% | 264 |
|
|
2017
Q2 | $898K | Hold |
13,175
| – | – | 0.05% | 251 |
|
|
2017
Q1 | $821K | Hold |
13,175
| – | – | 0.05% | 256 |
|
|
2016
Q4 | $720K | Hold |
13,175
| – | – | 0.04% | 257 |
|
|
2016
Q3 | $866K | Hold |
13,175
| – | – | 0.05% | 266 |
|
|
2016
Q2 | $796K | Hold |
13,175
| – | – | 0.05% | 269 |
|
|
2016
Q1 | $742K | Hold |
13,175
| – | – | 0.04% | 276 |
|
|
2015
Q4 | $895K | Hold |
13,175
| – | – | 0.05% | 266 |
|
|
2015
Q3 | $838K | Hold |
13,175
| – | – | 0.05% | 262 |
|
|
2015
Q2 | $839K | Hold |
13,175
| – | – | 0.05% | 261 |
|
|
2015
Q1 | $902K | Hold |
13,175
| – | – | 0.05% | 255 |
|
|
2014
Q4 | $927K | Hold |
13,175
| – | – | 0.06% | 254 |
|
|
2014
Q3 | $941K | Hold |
13,175
| – | – | 0.06% | 255 |
|
|
2014
Q2 | $979K | Hold |
13,175
| – | – | 0.06% | 256 |
|
|
2014
Q1 | $855K | Hold |
13,175
| – | – | 0.05% | 257 |
|
|
2013
Q4 | $782K | Hold |
13,175
| – | – | 0.05% | 265 |
|
|
2013
Q3 | $684K | Hold |
13,175
| – | – | 0.05% | 265 |
|
|
2013
Q2 | $623K | Buy |
+13,175
| New | +$671K | 0.05% | 269 |
|
Other funds holding AZN
American National Insurance's AZN Position: Q4 2021 in Review
American National Insurance sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 11,925 shares — an estimated $1.43M sold.
American National Insurance first reported a position in AZN in Q2 2013 and held it in 34 quarters. The position peaked at $1.43M in Q3 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.
- American National Insurance reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
- American National Insurance sold 11,925 AstraZeneca shares in Q4 2021, an estimated $1.43M.
- American National Insurance first reported a position in AstraZeneca in Q2 2013 and held it in 34 quarters.
- American National Insurance's AstraZeneca position peaked at $1.43M in Q3 2021.
- 949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.
Based on American National Insurance's 13F filing for Q4 2021, filed 9 Feb 2022.